<html>
<head>PUBMED IDs for ATP6V1G2</head>
<body bgcolor='#C5F0F2'><h1>ATP6V1G2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/12920609/'>Identification of 46 novel SNPs in the 130-kb region containing a myocardial infarction susceptibility gene on chromosomal band 6p21.</a> August 16  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/16101831/'>The haplotype block, NFKBIL1-ATP6V1G2-BAT1-MICB-MICA, within the class III-class I boundary region of the human major histocompatibility complex may control susceptibility to hepatitis C virus-associated dilated cardiomyopathy.</a> August 17  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16971954/'>Haplotype-specific gene expression profiles in a telomeric major histocompatibility complex gene cluster and susceptibility to autoimmune diseases.</a> September 15  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/26367242/'>Characterization of the platelet transcriptome by RNA sequencing in patients with acute myocardial infarction.</a> December 27  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27704156/'>Oxidative stress and gene expression profiling of cell death pathways in alpha-cypermethrin-treated SH-SY5Y cells.</a> October 6  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28256194/'>Polymorphic Variations Associated With Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients.</a> March 4  2017<br></body></html>
